Qiagen (QGEN) Stock Forecast & Price Target $50.42 +0.20 (+0.39%) Closing price 10/23/2026 03:59 PM EasternExtended Trading$50.38 -0.04 (-0.08%) As of 10/23/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest Qiagen - Analysts' Recommendations and Stock Price Forecast (2026) How MarketBeat Calculates Price Target and Consensus Rating Consensus Rating HoldBased on 15 Analyst RatingsSell0Hold11Buy4 Based on 15 Wall Street analysts who have issued ratings for Qiagen in the last 12 months, the stock has a consensus rating of "Hold." Out of the 15 analysts, 11 have given a hold rating, and 4 have given a buy rating for QGEN. Consensus Price Target $44.43-11.88% Downside According to the 15 analysts' twelve-month price targets for Qiagen, the average price target is $44.43. The highest price target for QGEN is $52.00, while the lowest price target for QGEN is $38.60. The average price target represents a forecasted downside of -11.88% from the current price of $50.42. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Get the Latest News and Ratings for QGEN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Qiagen and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. QGEN Analyst Ratings Over TimeTypeCurrent Forecast10/24/25 to 10/24/261 Month Ago9/24/25 to 9/24/263 Months Ago7/26/25 to 7/26/261 Year Ago10/24/24 to 10/24/25Strong Buy0 Strong Buy rating(s)1 Strong Buy rating(s)1 Strong Buy rating(s)0 Strong Buy rating(s)Buy4 Buy rating(s)4 Buy rating(s)4 Buy rating(s)3 Buy rating(s)Hold11 Hold rating(s)9 Hold rating(s)8 Hold rating(s)6 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)1 Sell rating(s)0 Sell rating(s)Consensus Price Target$44.43$43.51$43.34$52.31Forecasted Upside-11.88% Downside-2.39% Downside4.75% Upside0.67% UpsideConsensus RatingHoldHoldHoldHold QGEN Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History QGEN Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Qiagen Stock vs. The CompetitionTypeQiagenHealthcare CompaniesBroader MarketConsensus Rating Score 2.29 2.32 2.53Consensus RatingHoldHoldModerate BuyPredicted Upside-11.88% Downside1,399.90% Upside16.91% UpsideNews Sentiment RatingPositive NewsSee Recent QGEN NewsNeutral NewsPositive News Recent Analyst Forecasts and Stock Ratings Most Recent from Each Brokerage All Show All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action 10/24/2024 - 10/24/2026 Report Date Report Date From Report Date To 1M3M6MYTD1Y2Y3Y5Y More filters Fewer filters Done 0 Results Export DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails10/22/2026 DZ Bank5 of 5 stars DowngradeStrong-Buy ➝ Hold10/22/2026 JPMorgan Chase & Co.3 of 5 starsCasey WoodringNot RatedReiterated RatingOverweight ➝ Neutral$55.00 ➝ $52.00+3.25%10/22/2026 Robert W. Baird3 of 5 starsCatherine Schulte2 of 5 starsBoost TargetOutperform$50.00 ➝ $52.00+3.95%9/11/2026 Weiss RatingsSubscribe to MarketBeat All Access to unlock brokerage rankings UpgradeHold (C-) ➝ Hold (C)9/11/2026 Morgan StanleySubscribe to MarketBeat All Access to unlock brokerage rankingsSteve BeuchawSubscribe to MarketBeat All Access to unlock analyst rankingsReiterated RatingOverweight9/9/2026 UBS GroupSubscribe to MarketBeat All Access to unlock brokerage rankingsDan LeonardSubscribe to MarketBeat All Access to unlock analyst rankingsInitiated CoverageNeutral$52.00 ➝ $47.00+10.92%8/10/2026 CitigroupSubscribe to MarketBeat All Access to unlock brokerage rankingsPatrick DonnellySubscribe to MarketBeat All Access to unlock analyst rankingsReiterated RatingNeutral$38.00 ➝ $45.00+6.44%8/7/2026 Stifel NicolausSubscribe to MarketBeat All Access to unlock brokerage rankingsDaniel AriasSubscribe to MarketBeat All Access to unlock analyst rankingsSet Target$40.00-4.99%8/7/2026 BarclaysSubscribe to MarketBeat All Access to unlock brokerage rankingsLuke SergottSubscribe to MarketBeat All Access to unlock analyst rankingsSet TargetEqual Weight$38.00 ➝ $40.00-4.09%8/6/2026 Jefferies Financial GroupSubscribe to MarketBeat All Access to unlock brokerage rankings Reiterated RatingBuy$48.00+15.09% Get the Latest News and Ratings for QGEN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Qiagen and its competitors with MarketBeat's FREE daily newsletter. 7/15/2026 TD CowenSubscribe to MarketBeat All Access to unlock brokerage rankingsDan BrennanSubscribe to MarketBeat All Access to unlock analyst rankingsReiterated RatingHold7/14/2026 Berenberg BankSubscribe to MarketBeat All Access to unlock brokerage rankingsHarry GillisSubscribe to MarketBeat All Access to unlock analyst rankingsSet TargetBuy ➝ Hold$45.50+9.79%6/25/2026 Kepler Capital MarketsSubscribe to MarketBeat All Access to unlock brokerage rankings Set TargetHold$38.60-0.38%4/30/2026 Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access to unlock brokerage rankingsJan KochSubscribe to MarketBeat All Access to unlock analyst rankingsReiterated RatingBuy$43.00+26.65%4/29/2026 Zacks ResearchSubscribe to MarketBeat All Access to unlock brokerage rankings UpgradeStrong Sell ➝ Hold6/26/2025 Bank of AmericaSubscribe to MarketBeat All Access to unlock brokerage rankingsDerik De BruinSubscribe to MarketBeat All Access to unlock analyst rankingsBoost TargetBuy$52.63 ➝ $55.79+10.78%4/4/2025 Rothschild & Co RedburnSubscribe to MarketBeat All Access to unlock brokerage rankingsEd Ridley-DaySubscribe to MarketBeat All Access to unlock analyst rankingsDowngradeBuy ➝ NeutralAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 02:59 PM ET. QGEN Forecast - Frequently Asked Questions What is Qiagen's forecast for 2026? According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Qiagen is $44.43, with a high forecast of $52.00 and a low forecast of $38.60. Should I buy or sell Qiagen stock right now? 15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Qiagen in the last year. There are currently 11 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" QGEN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in QGEN, but not buy additional shares or sell existing shares. Does Qiagen's stock price have much downside? According to analysts, Qiagen's stock has a predicted downside of -11.88% based on their 12-month stock forecasts. Has Qiagen been upgraded or downgraded by Wall Street analysts recently? Over the previous 90 days, Qiagen's stock had 2 upgrades and 1 downgrade by analysts. What analysts cover Qiagen? Qiagen has been rated by research analysts at Barclays, Citigroup, DZ Bank, Jefferies Financial Group, JPMorgan Chase & Co., Morgan Stanley, Robert W. Baird, Stifel Nicolaus, UBS Group, and Weiss Ratings in the past 90 days. Do Wall Street analysts like Qiagen more than its competitors? Analysts like Qiagen less than other "healthcare" companies. The consensus rating score for Qiagen is 2.27 while the average consensus rating score for "healthcare" companies is 2.32. Learn more on how QGEN compares to other companies. Stock Forecasts and Research Tools Related Companies MTD Stock Forecast RVTY Stock Forecast MEDP Stock Forecast CRL Stock Forecast ICLR Stock Forecast TECH Stock Forecast AVTR Stock Forecast TXG Stock Forecast TWST Stock Forecast RGEN Stock Forecast Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Brokerages With Qiagen RecommendationsJPMorgan Chase & Co.Robert W. BairdWeiss RatingsMorgan StanleyUBS GroupCitigroupBarclaysStifel NicolausJefferies Financial GroupTD CowenBerenberg BankKepler Capital MarketsDeutsche Bank AktiengesellschaftZacks ResearchWall Street Zen MarketBeat monitors more than a dozen sources for Qiagen analyst ratings, with the most recent rating issued on 10/22/2026. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredElon Musk’s One Stock Retirement PlanStanley Druckenmiller once said you don't get rich diversifying into 50 mediocre assets - you get rich finding...Brownstone Research | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qiagen N.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share Qiagen With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
